Active substanceInterferon alfaInterferon alfa
Similar drugsTo uncover
  • Alfaferon
    solution for injections 
  • Interferon leukocyte human
    lyophilizate d / inhal. nazal. 
    SPbNIIVS FMBA, FSUE     Russia
  • Interferon leukocyte human fluid
    solution d / inhal. nazal. 
  • Interferon leukocyte human dry
    lyophilizate d / inhal. nazal. 
  • Interferon human leukocyte
    lyophilizate d / inhal. nazal. 
  • Inferon
    lyophilizate w / m 
  • Lokferon
    lyophilizate locally 
  • Dosage form: & nbsplyophilizate for the preparation of a solution for topical application
    Composition:Interferon human leukocyte purified concentrated protein synthesized in the culture of leukocyte cells of donor blood under the influence of the inductor virus, purified by micro- and ultrafiltration methods. "Lokferon" is a tablet or an amorphous white powder with an antiviral activity of at least 8000 IU / bottle. The filler and stabilizer is lactose or sucrose.
    Description:It is a tablet or an amorphous white powder.
    ATX: & nbsp

    L.03.A.B.01   Interferon alfa

    Pharmacodynamics:
    "Lokferon" has a wide range of antiviral and antibacterial activity.
    Indications:"Lokferon" is used to treat eye diseases of viral (herpesviral, adenoviral, etc.) etiology (conjunctivitis, keratitis, keratouveitis). The drug can be used as well as human leukocyte dry interferon for intranasal use.
    Contraindications:Has no contraindications.
    Dosing and Administration:

    The drug is used in the form of drops. The contents of the vial are dissolved in 1 ml of distilled or boiled water in the treatment of herpetic keratitis, in 2 ml in the treatment of adenoviral conjunctivitis (1 ml on the vial). Dissolution time 1 min. The drug solution should be clear and colorless, or have shades from light yellow to light pink color. Shelf life of the dissolved drug is 24 hours at a temperature of 2 to 8 ° C.

    In the acute stage of the disease, "Lokferon" is instilled in the eye 8 times a day in combination with basic therapy. As the inflammatory process decreases, the number of instillations decreases to 4-6 times a day. Depending on the severity of the course of the disease, the course of treatment is from 2 to 4 weeks.

    When treating the flu, "Lokferon" is bred in 4 ml of distilled or boiled water and instilled in 0.25 ml (5 drops) in each nasal passage in 1-2 hours for 2-3 days.

    With the goal of preventing influenza and acute respiratory infections, "Lokferon" is administered 0.25 ml (5 drops) in each nasal passage 2 times a day after 6 hours.

    "Lokferon" can be used at any age. The drug is not subject to application in the event of a violation of the integrity of the bottle and cap, marking, with a change in physical properties.

    Side effects:The drug does not give side effects. With prolonged use, no sensitization has been detected.
    Form release / dosage:Liofilizate for the preparation of a solution for topical application, 8000 ME.
    Packaging:In vials containing 8000 ME.
    Storage conditions:The preparation is stored and transported in accordance with SP 3.3.2.028-95 at a temperature of 2 to 8 ° C.
    Shelf life:
    12 months.
    Terms of leave from pharmacies:On prescription
    Registration number:P N001878 / 01-2002
    Date of registration:19.12.2008
    Expiration Date:Unlimited
    The owner of the registration certificate:BIOMED them. I.I.Mechnikova, OJSC BIOMED them. I.I.Mechnikova, OJSC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp03.04.2018
    Illustrated instructions
      Instructions
      Up